Material Information- Announcement of the 2026 Annual Shareholders’Meeting Approved the Proposal to release the Non-Competition Restrictions on Directors
1.Date of the shareholders’ meeting resolution:2026/06/17
2.Name and title of the managerial officer with permission to engage in competitive conduct:
(1)Maggie Chang; Director (Representative of Liu Handa Holdings, LLC)
(2)Toshiyo Chen; Director (Representative of Liu Handa Holdings, LLC)
(3)Willie Lin; Director (Representative of Liu Handa Holdings, LLC)
(4)Jo Shen; Director
(5)James Hsu; Independent Director
(6)Patricia Chou; Independent Director
3.Items of competitive conduct in which the officer is permitted to engage:
(1)Maggie Chang; Director (Representative of Liu Handa Holdings, LLC)：
Director of Haniverse Pharmaceuticals Limited
(2)Toshiyo Chen; Director (Representative of Liu Handa Holdings, LLC)：
Director of Haniverse Pharmaceuticals Limited
(3)Willie Lin; Director (Representative of Liu Handa Holdings, LLC)：
Director of PrecisemAb Biotech CO., LTD.
(4)Jo Shen; Director：
1.Independent Director of Acepodia, Inc.
2.Advisory Board Member, College of Business, National Chengchi
University
(5)James Hsu; Independent Director：
1.Member of the Audit Committee and Remuneration Committee of Applied
BioCode Corporation
2.Remuneration Committee Member, LIBO PHARMA CORP.
(6)Patricia Chou; Independent Director：Independent Director of MiTAC
Digital Technology Corporation
4.Period of permission to engage in the competitive conduct:The period of being director of the Company.
5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):The proposal was approved by shareholders representing more than one-half of the Company’s total issued shares, with the affirmative votes of more than two-thirds of the voting rights present at the meeting.
6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below):NA
7.Company name of the mainland China enterprise and the officer’s position in the enterprise:NA
8.Address of the mainland China enterprise:NA
9.Operations of the mainland China enterprise:NA
10.Impact on the company’s finance and business:None
11.If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:NA
12.Any other matters that need to be specified:None